Cambridge Investment Research Advisors, Inc. Compugen LTD Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Compugen LTD stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 11,250 shares of CGEN stock, worth $18,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,250
Previous 11,525
2.39%
Holding current value
$18,900
Previous $17,000
11.76%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CGEN
# of Institutions
79Shares Held
16.3MCall Options Held
59.3KPut Options Held
32.1K-
Silverarc Capital Management, LLC3.03MShares$5.1 Million1.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.33MShares$2.23 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.31MShares$2.21 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.07MShares$1.8 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.71 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $146M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...